Skip to content
← Back to this collection

PUBLICATIONS · 30276762

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Target Oncol
Publication date
2018 Oct
First author
Kummar S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kummar S
      type
      Author
    2. name
      Lassen UN
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kummar S
      type
      Author
    2. name
      Lassen UN
      type
      Author
    bibliography ids
    1. nci-bib-da6192720aae92dae36e0043
    book metadata
    content sha256
    50f5d8910e0755c5ffafb663108ec6b0a5f1418b14c608cc2c7f6964f87b2268
    document type
    citation
    dois
    1. 10.1007/s11523-018-0590-1
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30276762
    immutable id
    pubmed:30276762@50f5d8910e0755c5ffafb663108ec6b0a5f1418b14c608cc2c7f6964f87b2268
    journal
    abbreviation
    Target Oncol
    issn electronic
    1776-260X
    issn print
    1776-2596
    issue
    5
    name
    Targeted oncology
    nlm unique id
    101270595
    pages
    545-556
    volume
    13
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30276762
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      bb255f256d5f7393fd2d8e7411ebb5c9d619adb95237d67018726d08bbd7a4fe
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Oct
      precision
      month
      year
      2018
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      3. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30276762/
      title
      TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

      Preserved source evidence · Not medical advice